切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2021, Vol. 08 ›› Issue (03) : 119 -124. doi: 10.3877/cma.j.issn.2095-7157.2021.03.007

综述

早期胃癌内镜下切除术后的复发及治疗现状
李宝1, 柴宁莉1, 令狐恩强1,()   
  1. 1. 100853 北京,解放军总医院第一医学中心消化内科医学部
  • 收稿日期:2021-06-23 出版日期:2021-08-15
  • 通信作者: 令狐恩强
  • 基金资助:
    国家重点研发计划(2016YFC1303601)

Recurrence and treatment of early gastric cancer after endoscopic resection

Bao Li1, Ningli Chai1, Enqiang Linghu1,()   

  1. 1. Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
  • Received:2021-06-23 Published:2021-08-15
  • Corresponding author: Enqiang Linghu
引用本文:

李宝, 柴宁莉, 令狐恩强. 早期胃癌内镜下切除术后的复发及治疗现状[J/OL]. 中华胃肠内镜电子杂志, 2021, 08(03): 119-124.

Bao Li, Ningli Chai, Enqiang Linghu. Recurrence and treatment of early gastric cancer after endoscopic resection[J/OL]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(03): 119-124.

随着内镜技术的发展和进步,内镜下切除术已成为早期胃癌治疗的首选方式,与传统外科手术比较有相当的长期生存率,但是随访过程中肿瘤的复发及复发后的治疗方式选择仍有一定争议。目前多依据复发发生的时间及与原发病变的位置关系对复发进行分类,补充外科手术或内镜下再次切除是复发病变治疗可选择的主要方式,也具有一定的临床安全性和有效性。本文将从内镜下切除术后复发的定义及分类、复发的影响因素、治疗选择等方面对当前复发及治疗的现状进行梳理,以期对早期胃癌内镜下切除术后复发病变的随访管理及个性化治疗提供有价值的参考。

With the development and advancement of endoscopic technique, endoscopic resection has been applied widely to the treatment of early gastric cancer, which has a similar long-term survival rate compared with traditional surgery. However, the recurrence of tumors during follow-up and the selection of treatment methods after recurrence are still inconclusive. At present, recurrence is mostly classified according to the time of recurrence and the distance with the location of the primary lesion. Supplementary surgery or repeated endoscopic resection is the main treatment of recurrent lesions, which also have definite safety and effectiveness. In this paper, the definition and classification of recurrence after endoscopic resection, the influencing factors of recurrence and treatment of recurrence were reviewed, in order to provide valuable reference for the follow-up management and individualized treatment of recurrence after endoscopic resection.

表1 内镜下切除术后复发的分类及定义
表2 2006~2018年内镜下切除术后残留或局部复发病变再次ESD治疗研究汇总发表
[1]
Sung H,,Ferlay J,,Siegel RL,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin202171(3): 209-249.
[2]
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition) [J]. Gastric cancer, 2021, 24(1): 1-21.
[3]
北京市科委重大项目《早期胃癌治疗规范研究》专家组. 早期胃癌内镜下规范化切除的专家共识意见(2018,北京)[J]. 中华消化内镜杂志201936(6): 381-392.
[4]
Gotoda T,,Kondo H,,Ono H,et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases[J]. Gastrointest Endosc199950(4): 560-563.
[5]
Zhao Y,,Wang C. Long-Term Clinical Efficacy and Perioperative Safety of Endoscopic Submucosal Dissection versus Endoscopic Mucosal Resection for Early Gastric Cancer: An Updated Meta-Analysis [J]. Biomed Res Int20182018: 3152346.
[6]
Ahn JY,,Jung HY,,Choi KD,et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications[J]. Gastrointest Endosc201174(3): 485-493.
[7]
Fan T,,Sun Q,,Cao S,et al. Clinical outcomes of early gastric cardiac cancer treated with endoscopic submucosal dissection in patients with different indications[J]. BMC Gastroenterol202121(1): 119.
[8]
Ono H,,Yao K,,Fujishiro M,et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)[J]. Dig Endosc, 202133(1): 4-20.
[9]
Nasu J,,Doi T,,Endo H,et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection[J]. Endoscopy200537(10): 990-993.
[10]
Yoo JH,,Shin SJ,,Lee KM,et al. How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas?[J]. J Clin Gastroenterol201347(2): e17-22.
[11]
Nakajima T, Oda I,,Gotoda T, et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?[J]. Gastric Cancer20069(2): 93-98.
[12]
Abe S,,Oda I,,Minagawa T,et al. Metachronous Gastric Cancer Following Curative Endoscopic Resection of Early Gastric Cance[J]. Clin Endosc201851(3): 253-259.
[13]
Park SE,,Kim SH,,Kim SG,et al. Local or extragastric recurrence after incomplete endoscopic submucosal dissection of early gastric cancer: risk factors and the role of CT[J]. Abdom Radiol (NY), 201843(12): 3250-3259.
[14]
Lee JY,,Cho KB,,Kim ES,et al. Risk factors for local recurrence after en bloc endoscopic submucosal dissection for early gastric cance[J]. World J Gastrointest Endosc20168(7): 330-337.
[15]
Nam HS,,Choi CW,,Kim SJ,et al. Endoscopic predictive factors associated with local recurrence after gastric endoscopic submucosal dissection[J]. Scand J Gastroenterol201853(8): 1000-1007.
[16]
Lee JH,,Kim JH,,Kim DH,et al. Is Surgical Treatment Necessary after Non-curative Endoscopic Resection for Early Gastric Cancer?[J]. J Gastric Cancer201010(4): 182-187.
[17]
Sunagawa H,,Kinoshita T,,Kaito A,et al. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases[J]. Surg Today201747(2): 202-209.
[18]
Yajima H,,Omura N,,Takahashi N,et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cance[J]. Int Surg2015100(1): 169-172.
[19]
Lee H,,Yun WK,,Min BH,et al. A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cance[J]. Surg Endosc201125(6): 1985-1993.
[20]
Choi JY,,Jeon SW,,Cho KB,et al. Non-curative endoscopic resection does not always lead to grave outcomes in submucosal invasive early gastric cance[J]. Surg Endosc201529(7): 1842-1849.
[21]
Abdelfatah MM,,Barakat M,,Ahmad D,et al. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol201931(4): 418-424.
[22]
Jang MY,,Cho JW,,Oh WG,et al. Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection[J]. Korean J Intern Med201328(6): 687-693.
[23]
Sekiguchi M,,Suzuki H,,Oda I,et al. Risk of recurrent gastric cancer after endoscopic resection with a positive lateral margin[J]. Endoscopy201446(4): 273-278.
[24]
Park JC,,Lee SK,,Seo JH,et al. Predictive factors for local recurrence after endoscopic resection for early gastric cancer: long-term clinical outcome in a single-center experience[J]. Surg Endosc201024(11): 2842-2849.
[25]
黄戬,章庆伟,张昕恬,等. 早期胃癌内镜下切除后复发及异时癌的影响因素探究 [J]. 中华消化内镜杂志20187(35): 492-496.
[26]
Takenaka R,,Kawahara Y,,Okada H,et al. Risk factors associated with local recurrence of early gastric cancers after endoscopic submucosal dissection[J]. Gastrointest Endosc2008, 68(5): 887-894.
[27]
Kim TK,,Kim GH,,Park DY,et al. Risk factors for local recurrence in patients with positive lateral resection margins after endoscopic submucosal dissection for early gastric cance[J]. Surg Endosc201529(10): 2891-2898.
[28]
Cha JH,,Jang JS. Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection[J]. Turk J Gastroenterol202031(1): 36-41.
[29]
Park WY,,Lee SJ,,Kim YK,et al. Occurrence of metachronous or synchronous lesions after endoscopic treatment of gastric epithelia dysplasia- impact of histologic features of background mucosa[J]. Pathol Res Pract2018214(1): 95-99.
[30]
Nam HS,,Kim HW,,Choi CW,et al. Characteristics of overlooked synchronous gastric epithelial neoplasia after endoscopic submucosal dissection[J]. Medicine201897(39): e12536.
[31]
Maehata Y,,Nakamura S,,Fujisawa K,et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cance[J]. Gastrointest Endosc201275(1): 39-46.
[32]
Venerito M,,Malfertheiner P. Preneoplastic conditions in the stomach: always a point of no return?[J]. Dig Dis201533(1): 5-10.
[33]
Kim JL,,Kim SG,,Kim J,et al. Clinical Outcomes of Metachronous Gastric Cancer after Endoscopic Resection for Early Gastric Cance[J]. Gut Liver202014(2): 190-198.
[34]
Lee MW,,Kim GH. Metachronous Gastric Cancer: Another Hurdle for Successful Endoscopic Treatment for Early Gastric Cancer?[J]. Gut Liver202014(2): 145-147.
[35]
Yokoi C,,Gotoda T,,Hamanaka H,et al. Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection[J]. Gastrointest Endosc200664(2): 212-218.
[36]
Bae SY,,Jang TH,,Min BH,et al. Early additional endoscopic submucosal dissection in patients with positive lateral resection margins after initial endoscopic submucosal dissection for early gastric cance[J]. Gastrointest Endosc201275(2): 432-436.
[37]
Sekiguchi M,,Suzuki H,,Oda I,et al. Favorable long-term outcomes of endoscopic submucosal dissection for locally recurrent early gastric cancer after endoscopic resection[J]. Endoscopy201345(9): 708-713.
[38]
Hoteya S,,Iizuka T,,Kikuchi D,et al. Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection[J]. Gastric Cancer201417(4): 697-702.
[39]
Jung DH,,Youn YH,,Kim JH. Secondary endoscopic submucosal dissection for locally recurrent or incompletely resected gastric neoplasms[J]. World J Gastroenterol201824(33): 3776-3785.
[40]
Lee KM,,Kim YB,,Sin SJ,et al. Argon plasma coagulation with submucosal saline injection for gastric adenoma on outpatient basis[J]. Dig Dis Sci200954(12): 2623-2628.
[41]
Kitamura T,,Tanabe S,,Koizumi W,et al. Argon plasma coagulation for early gastric cancer: technique and outcome[J]. Gastrointest Endosc200663(1): 48-54.
[42]
Oh S,,Kim SG,,Choi JM,et al. Ablation of residual gastric tumor by argon plasma coagulation after endoscopic resection[J]. Surg Endosc201731(3): 1093-1100.
[43]
Kim HW,,Kim JH,,Park JC,et al. Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cance[J]. Gastrointest Endosc201786(5): 849-856.
[44]
Nagano H,,Ohyama S,,Fukunaga T,et al. Indications for gastrectomy after incomplete EMR for early gastric cance[J]. Gastric Cancer20058(3): 149-154.
[45]
Tian YT,,Ma FH,,Wang GQ,et al. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience[J]. World J Gastroenterol201925(29): 3996-4006.
[46]
Hatta W,,Gotoda T,,Oyama T,et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan[J]. J Gastroenterol201752(2): 175-184.
[47]
令狐恩强,冯佳,马晓冰,等. 内镜下射频消融术治疗食管和胃低级别上皮内瘤变的临床研究 [J/CD]. 中华胃肠内镜电子杂志20152(1): 14-17.
[48]
王楠钧,柴宁莉,令狐恩强,等. 内镜下射频消融术治疗胃低级别上皮内瘤变的临床研究[J/CD]. 中华胃肠内镜电子杂志20207(3): 117-120.
[49]
Leung WK,,Tong DK,,Leung SY,et al. Treatment of Gastric Metaplasia or Dysplasia by Endoscopic Radiofrequency Ablation: A Pilot Study[J]. Hepatogastroenterology201562(139): 748-751.
[50]
Fujishiro M,,Goto O,,Kakushima N,et al. Endoscopic submucosal dissection of stomach neoplasms after unsuccessful endoscopic resection[J]. Dig Liver Dis200739(6): 566-571.
[51]
Kikuchi D,,Iizuka T,,Hoteya S,et al. Safety and efficacy of secondary endoscopic submucosal dissection for residual gastric carcinoma after primary endoscopic submucosal dissection[J]. Digestion201286(4): 288-293.
[52]
Shimamura Y,,Ishii N,,Nakano K,et al. Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection[J]. World J Gastrointest Endosc, 20135(12): 600-604.
[53]
Higashimaya M,,Oka S,,Tanaka S,et al. Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection[J]. Gastrointest Endosc201377(2): 298-302.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[6] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[7] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[8] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[9] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[10] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[11] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[12] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[13] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?